Results are not guaranteed, and assessment with a clinician is recommended
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
KimDLeeDTrackmanPCRoyS.Effects of high glucose-induced Lysyl oxidase propeptide on retinal endothelial cell survival: implications for diabetic retinopathy
MS is a pathological condition defined by a cluster of metabolic disorders that increases the risk of cardiovascular diseases and diabetes
He L, Zhang L, Peng Y, He Z (2025) Selenium in cancer management: exploring the therapeutic potential
